Brief: Shenzhen Hepalink Says OncoQuest Inc Plans To Sell Assets To South Korea's Dual Industrial
21/04/2020 02:07
April 21 (Reuters) - Shenzhen Hepalink Pharmaceutical Group
Co Ltd 002399.SZ :
* SAYS ITS U.S. UNIT'S JOINT STOCK COMPANY ONCOQUEST INC
PLANS TO
SELL DRUG-RELATED ASSETS TO SOUTH KOREA'S DUAL INDUSTRIAL CO LTD
Source text in Chinese: https://bit.ly/3cw9gFR
Further company coverage: 002399.SZ 078590.KQ
(Reporting by Hong Kong newsroom)
((twinnie.siu@thomsonreuters.com; 852-2841 5763;))
Recent news on Hyulim A-Tech
See all newsBrief: OncoQuest Signs Deal To Sell Drug Portfolio To Dual Industrial For $300 Mln
Brief: Shenzhen Hepalink Says OncoQuest Inc Plans To Sell Assets To South Korea's Dual Industrial
S.Korea stocks bounce back; Fed in focus
S.Korea stocks rebound as Fed comes into focus
S.Korea's Dual Industrial plunges after co drops bid to buy crypto exchange stake